Home » Topics » Medical technology

Medical technology
RSS

Consortium cites MammaPrint for breast cancer prognosis

Dec. 26, 2007

New breast cancer biomarkers may lead to improved treatment

Dec. 26, 2007

By Amanda Pedersen

Philips to acquire Respironicsin deal valued at $5.1 billion

Dec. 26, 2007

GE Healthcare in pact to distribute Draximage s Sestamibi product

Dec. 26, 2007

Sunrise releases 3 top execs in wake of financial fact-finding

Dec. 26, 2007

CMS: no to FDG-PET coverage, for lack of assessment criteria

Dec. 26, 2007

By Mark McCarty

Redwood Toxicology Laboratory acquired by IMI for $99 million

Dec. 26, 2007

Biotech – Big Pharma Collaborations: Modified And Terminated Agreements, Nov. 2 - Dec. 19, 2007

Dec. 24, 2007

Manufacturing, Marketing And Distribution Agreements Between Biotech And Pharmaceutical Companies: Nov. 2 - Dec. 19, 2007

Dec. 24, 2007

Collaborations Between Biotech And Pharmaceutical Companies: Nov. 2 - Dec. 19, 2007

Dec. 24, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 15, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
Advancing the 'best of both' – BMS, Hengrui enter $15.2B deal
BioWorld
In a deal potentially worth up to $15.2 billion, Jiangsu Hengrui Pharmaceuticals Co. Ltd. is joining efforts with Bristol Myers Squibb Co. to advance 13 early...
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...
Roche secures CE mark for Alzheimer’s blood test
BioWorld
Roche Holding AG secured CE marking for the Elecsys plasma phosphorylated-tau 217 blood test designed to rule in and rule out amyloid pathology, a hallmark of...